Back to results
WithdrawnPhase 4

Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease

NCT06169826

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Atrium Health Wake Forest Baptist

Winston-Salem, North Carolina, United States

View on ClinicalTrials.gov
Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease — TrialFind